Main Subject - Internet and Businesses Online

Why don't CXO's take advantage of the best productivity tool available today? Are they ignorant, or are we just not speaking their language?

Forrester Research has just released a report on Enterprise RSS,

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

and has struck a chord that many are acknowledging - we're drowning in data. Thanks to Richard McManus of Read/Write Web; we-who-don't-have-subscriptions get a glimpse into the findings:

Richard posted:

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

"I think we all know about the issue of information overload - and the resulting value of good filters and smart aggregators. In some ways the problem is worse for enterprise employees - because as well as

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

external news sources, they have potentially hundreds of internal RSS feeds to track via company blogs and wikis."

Forrester: "Enterprise RSS turbo-charges the benefits of unmanaged RSS adoption with inte

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

nal content syndication, filtering, and collaboration. It also provides increased security and reduces IT requirements."

I think the problem with "this whole RSS thing" is that we don't explain very well w

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

hat it is or what it can do for a typical enterprise. They're not ignorant, we just don't explain things very well...

So here are my top three benefits of RSS for business executives to no

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

e:

1. The power of all being on the same page. I use Basecamp (a project management system) with several clients, and am automatically notified via RSS when anything is updated on any pro

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ject. Notifications automatically go to Outlook - which then go to my Blackberry.

Every team member automatically knows the status of a project because we subscribe to changes/up

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ates - no matter where we are in the world.

Any executive can get those same notifications and alerts - they'll have access to key information "just in time" rather than waiting f

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

or team updates.

2. The right people have the right information at the right time. Let's break this one down:

The right people - I have a client who's the CEO of a co

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

pany. His IT staff forgot to add him to one of the email groups in his organization - so he never got email notices sent to that particular group (which happened to be an all-company email list).

This kin

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

of thing happens in organizations every day. I can't even imagine how much time IT folks spend keeping email groups up to date. With Enterprise RSS; Stephen would have the choice and control<

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

/strong> to subscribe to any feed that interested him.

The right information - Scott at Attensa tracks their marketplace using their platform. He posts information on an int

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rnal Wiki when he finds something substantive to note about a competitor, mergers in the market, what not. Anyone in the organization who needs market information (R&D / product management / finance) can op

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

t into Scott's marketplace news feed and have the information delivered to them without having to search for it on their own. Suddenly you're leveraging the intelligence of others

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

n your work.

The right time - information is delivered as it appears online. Imagine you're a PR professional, needing to know when your product or service is mentioned anywhere

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

online. Better than plain old Google alerts; Attensa lets you know instantly when anyone categorizes (tags) a blog post or mention with your keywords on Technorati.

3. The business retains th

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

knowledge when key employees leave. A business partner of mine says that every time an employee leaves their organization, it costs the company about $150,000 to recruit, hire and train a new emp

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

loyee.

Imagine being able to retain and pass along the key observations, news and subscriptions (often the nuances of knowledge that are impossible to teach) of the person who's left the company and passin

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

it along to the new hire via their persistent searches, feed subscriptions and such. My bet is that training and ramp up time would be cut significantly through this efficient automatic knowledge transfer

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Main Subject - Three Key Benefits of Enterprise RSS For Any CXO

Related Articles: